Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nagi Reddy Seelam Concord Drugs Ltd - 538965 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nagi Reddy Seelam Concord Drugs Ltd - 538965 - Unaudited Financial Results For The Quarter Ended 31.12.2020
Unaudited financial results for the quarter ended 31.12.2020 Concord Drugs Ltd - 538965 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results For The Quarter Ended 31.12.2020
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve the un-audited financial results for the quarter ended 31.12.2020 Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 Concord Drugs Ltd - 538965 - Shareholding for the Period Ended December 31, 2020
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Concord Drugs Ltd - 538965 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NAGI REDDY SEELAMDesignation :- Managing Director / Whole Time Director Concord Drugs Ltd - 538965 - Closure of Trading Window
Closure of Trading Window for the Quarter ended 31.12.2020 Concord Drugs Ltd - 538965 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Concord Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers report